Inpatient Smoking Cessation Pilot Program

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

EARLY_PHASE1

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-01

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are implementing a stepwise approach to cessation with a public health focus to improve health outcomes for the investigators' pediatric patients. The investigators are focusing on addressing caregiver smoking as a modifiable risk factor during time of child's hospitalization as a window of opportunity to provide counseling and education to families on secondhand and third hand smoke exposure as well as information on NRT products to heighten caregiver contemplation for quitting. One of the central goals of the investigators' project is to increase immediate access to Nicotine Replacement Therapy (NRT) resources for families during hospitalization which pediatric providers could potentially dose and prescribe to caregivers who are screened positive for smoking. Long-term cessation care is provided by referrals to both the MD Quitline and the John Hopkins Tobacco Treatment Clinic. Both are provided to allow participants options that the participants would find preferable from an insurance and provider perspective.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Identifying Optimal Smoking Cessation Intervention Components (Cessation)

NCT01116986

Smoking Smoking Cessation Nicotine Dependence

COMPLETED PHASE4

Developing and Pilot Testing a Remote Smoking Cessation Digital Therapeutic for Individuals With Serious Mental Illness

NCT05031416

Smoking Cessation

WITHDRAWN NA

A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users

NCT01334736

Tobacco Dependence

COMPLETED NA

Smoking Cessation Intervention: Effectiveness in Primary Care

NCT00296647

Tobacco Dependence

COMPLETED PHASE4

Adolescent Inpatient Tobacco and ENDS Intervention

NCT05936099

Vaping Smoking

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cessation intervention

All participants will receive nicotine replacement therapy and a referral to both Maryland Quitline and Johns Hopkins Tobacco Treatment Clinic for continued cessation care.

Nicotine replacement therapy: Nicoderm patches, gum, lozenges

* Low nicotine dependence: Lozenge (2 mg) or Gum (2 mg) or Patch (7 mg)
* Moderate nicotine dependence: Patch (14 mg) and Lozenge (2 mg) or Gum (2 mg)
* High nicotine dependence: Patch (21 mg) and Lozenge (4 mg) or Gum (4 mg)

Regardless of the level of nicotine addiction and subsequent dose of nicotine replacement therapy (NRT), participants of this trials are described as "recipients of NRT products".

Group Type EXPERIMENTAL

Nicotine lozenge

Intervention Type DRUG

Nicotine replacement therapy

Nicotine gum

Intervention Type DRUG

Nicotine replacement therapy

Nicotine patch

Intervention Type DRUG

Nicotine replacement therapy

Maryland Quitline

Intervention Type OTHER

Telephone-based tobacco cessation service

John Hopkins Tobacco Treatment Clinic

Intervention Type OTHER

Clinic-based tobacco cessation service

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nicotine lozenge

Nicotine replacement therapy

Intervention Type DRUG

Nicotine gum

Nicotine replacement therapy

Intervention Type DRUG

Nicotine patch

Nicotine replacement therapy

Intervention Type DRUG

Maryland Quitline

Telephone-based tobacco cessation service

Intervention Type OTHER

John Hopkins Tobacco Treatment Clinic

Clinic-based tobacco cessation service

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Caregivers of patients on an inpatient unit at Johns Hopkins Children's Center who self-identify as tobacco users and wish to initiate tobacco cessation